Speakers
Sabrina Aery
Executive Director US Government Programs
Bristol Myers Squibb
Understanding the 340B Program: Implications for Market Access Strategy
Biography
Sabrina Aery is currently an Executive Director of US & Global Health Strategy Analytics and Innovation at Bristol Myers Squibb where she has worked the past 22 years. During her tenure at BMS she has held roles in Global Market Access, Commercial, US Policy and US Market Access with a continuous focus on the intersection of policy and the business. She has been a manufacturer trainer at Apexus 340B Universities and was a leader among manufacturers in NCDPD work with CMS related to duplicate discounts. Overall, she has 28 years of experience working for pharmaceutical companies and has also held previous roles working for a health plan, University Hospital health system and State Department of Health. She has a deep appreciation for the various stakeholder points of view across the US healthcare continuum.